Integrating Molecular Oncology into Therapeutic Strategies for Prostate Cancer-Reference-Cited by-同舟云学术

Integrating Molecular Oncology into Therapeutic Strategies for Prostate Cancer

Published:2009-01 Issue:3 Volume:8 Page:114-119
ISSN:1569-9056
Container-title:European Urology Supplements
language:en
Short-container-title:European Urology Supplements

Author:

Gross-Goupil Marine,Massard Christophe,Fizazi Karim

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon, France: IARC Press; 2004.

2. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points;Tannock;J Clin Oncol,1996

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

5. Prostate cancer;Nelson;N Engl J Med,2003

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostatectomy samples;Scandinavian Journal of Urology and Nephrology;2011-01-18

2. Mononuclear nine-coordinate Na[SmIII(edta)(H2O)3] · 5H2O and one dimensional unlimited ladderlike eight-coordinate {[SmIII(Hpdta)(H2O)] · 2H2}O n Complexes: Synthesis and Structural Determination;Russian Journal of Inorganic Chemistry;2010-10

3. Current World Literature;Current Opinion in Endocrinology, Diabetes & Obesity;2010-06